中国医药科学2024,Vol.14Issue(9) :31-35.DOI:10.20116/j.issn2095-0616.2024.09.07

真核翻译起始因子4G1与恶性肿瘤的研究进展

Research progress of eukaryotic translation initiation factor 4G1 and malignant tumor

彭秀娟 张丹凤
中国医药科学2024,Vol.14Issue(9) :31-35.DOI:10.20116/j.issn2095-0616.2024.09.07

真核翻译起始因子4G1与恶性肿瘤的研究进展

Research progress of eukaryotic translation initiation factor 4G1 and malignant tumor

彭秀娟 1张丹凤2
扫码查看

作者信息

  • 1. 佳木斯大学临床医学院,黑龙江佳木斯 154000
  • 2. 佳木斯大学附属第一医院妇产科,黑龙江佳木斯 154000
  • 折叠

摘要

真核翻译起始因子 4G1(eIF4G1)是一种大型支架蛋白,在真核生物mRNA翻译起始过程中,可作为蛋白质的对接位点,介导帽依赖性与非帽依赖性翻译启动.eIF4G1 是翻译调控中的重要靶标,被认为参与多种肿瘤细胞的生长、迁移、增殖、侵袭和凋亡.近年来,随着对eIF4G1 研究的深入,临床对其作用和功能也有了更深的理解,本文总结相关文献,对eIF4G1 的功能、研究现状及与肿瘤的关系做一简要综述.

Abstract

Eukaryotic translation initiation factor 4 gamma 1(eIF4G1)is a large scaffold protein,which can serve as a docking site for proteins during mRNA translation initiation of eukaryotes,and mediate cap-dependent and cap-independent translation initiation.eIF4G1 is an important target in translation regulation,which is considered to be involved in the growth,migration,proliferation,invasion and apoptosis of various tumor cells.In recent years,with the in-depth study of eIF4G1,we have a deeper understanding of its effects and functions.This article will summarize the relevant literature,and briefly summarize the function,research status and relationship with tumors of eIF4G1.

关键词

真核翻译起始因子4G1/帽依赖性翻译/真核翻译起始因子/肿瘤/mRNA

Key words

Eukaryotic translation initiation factor 4 gamma 1/Cap-dependent translation/Eukaryotic translation initiation factor/Tumor/mRNA

引用本文复制引用

出版年

2024
中国医药科学
海峡两岸医药卫生交流协会 二十一世纪联合创新(北京)医药科学研究院

中国医药科学

影响因子:1.083
ISSN:2095-0616
段落导航相关论文